Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immune Targeting Systems turns sights on commercial goals

This article was originally published in Scrip

Executive Summary

By hiring two industry veterans, Immune Targeting Systems has flagged its intention to shift its focus to include commercial goals. The UK biotech focusing on the development of vaccines that promote T-cell responses to viruses and cancers has announced the appointment of Dr Benjamin Chen as executive chairman and Dr Kevin Fitzgerald as chief operating officer. Armed with Phase I data from two trials of the company's lead pandemic flu programme, the new leadership team intends to step up biopartnering activities and find a new investor to lead its existing backers in a series B round.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC018779

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel